1 Background

Eldoret Cancer Registry was established in 1999. It is located in the Faculty of Medical Sciences of Moi University, Department of Haematology and Blood Transfusion. The registry records details of all cancer patients diagnosed and treated in hospitals of Eldoret town, and aims to be population-based for the district of Uasin Gishu, in the Rift Valley Region of Kenya (pop. 2009: 894,179). As well as the Director (Dr N. Buziba), the registry has three registrars, Gladys Chesumbai , Jacqueline Gavana, and Jane Chepkosgei. Because of shortage of funds in the last 6 years, the staff work only part time basis on registry duties. Case-finding uses three types of source: hospital records departments, pathology and death

2 Datasource

The largest hospital is Moi Teaching and Referral Hospital which also acts as the Province General Hospital. Cases are identified from the disease index (completed by records staff in ICD-10) and details of cases abstracted from case records onto a registry form. The registrars also visits private hospitals (Eldoret, Elgon View, Medi-Heal Fertility Hospital, St. Lukes and Reale Hospital) and the Eldoret Hospice at regular intervals to identify cancer cases, although because of financial constraints, visits were widely spaced in recent years. There is only one public pathology lab. Serving the District (in Moi Teaching and Referral Hospital), with four pathologists and 2 private pathology labs. The registrar abstracts details of all cancer diagnoses (address is usually unavailable). Haematological malignancies are all diagnosed by the registry director and his junior- Dr. Lotodo (Department of Haematology and Blood Transfusion).

Death registration is virtually universal (home deaths should also be autopsied, but this is a rare event). The death certificate may not be issued for some weeks after death, however. Deaths at home are certified by the village chief, based on relatives’ assessments, and are of very questionable accuracy (often just “cancer”).

Cases are coded in the registry, and data entry and management is by CANREG-5. By January 2013, some 16,000 cases had been registered, about one half of which are in residents of Uasin Gishu district.

3 Study Population

Eldoret: Situated some 330 km northwest of Nairobi, Eldoret is the largest city and the administrative capital of Uasin Gishu County.

Moi’s Bridge: Located some 40 km north of Eldoret along Eldoret – Kitale road, Moi’s bridge is a small yet an important agricultural town.

Burnt Forest: Sited some 35 kilometers to Eldoret, Burnt Forest is the first major town as you approach Eldoret from Nairobi.

Turbo: Turbo is a small agricultural town located about 31 km west of Eldoret town along Eldoret -Webuye road.

Others: Outside the county

drawing

4 Objective

The main objective of this study/analysis is to assess the incidence and prevalence of different cancer types from 2000 to 2020

5 Results for 2001 to 2005

5.1 Data Quality Assessment

5.1.1 DQA Summary Tables

Data summary

Name	clean.df
Number of rows	77271
Number of columns	50
_______________________
Column type frequency:
character	7
factor	22
logical	1
numeric	20
________________________
Group variables	None

Variable type: character

skim_variable	n_missing	complete_rate	min	max	n_unique
SOURCE2	65159	0.16	1	2	68
SOURCE3	75280	0.03	1	2	46
SOURCE4	76898	0.00	2	2	23
PRIMARY_	762	0.99	2	3	242
ICD10	12702	0.84	3	4	337
ICCC	18351	0.76	1	3	79
DATEB	1055	0.99	1	8	3508

Variable type: factor

skim_variable	n_missing	complete_rate	ordered	n_unique	top_counts
SOURCE1	128	1.00	FALSE	84	MR&: 29327, HIS: 12700, DEA: 5128, HAE: 3650
CHECKS	0	1.00	FALSE	4	Don: 63898, Not: 12844, Don: 483, Don: 46
ADRCODE	0	1.00	FALSE	8	Unk: 62687, Soy: 2662, TUR: 2574, KAP: 2208
T	71540	0.07	FALSE	8	T3: 1765, T4: 1582, T2: 1417, T1: 488
M	71601	0.07	FALSE	4	M0: 3188, M+: 1704, M1: 444, #!N: 334
TRIBE	741	0.99	FALSE	48	Kal: 20583, LUH: 14740, LUO: 9674, Nan: 7898
Sex	1	1.00	FALSE	2	Fem: 40776, Mal: 36494
Morphology	70	1.00	FALSE	317	Squ: 13504, Ade: 9154, Inf: 6305, Neo: 6188
Behaviour	42	1.00	FALSE	4	Mal: 77131, In : 54, Unc: 40, Ben: 4
Basis of Diagnosis	64	1.00	FALSE	10	His: 59423, Cyt: 10434, Cli: 4147, Dea: 1613
Stage	29624	0.62	FALSE	7	Unk: 26632, Sta: 11193, Sta: 5833, Sta: 2606
Grade	6766	0.91	FALSE	9	Unk: 48680, Gra: 9860, Gra: 7040, Gra: 4387
Surgery	3990	0.95	FALSE	3	No: 42280, Unk: 19053, Yes: 11948
Radio Therapy	4033	0.95	FALSE	3	No: 44575, Unk: 20113, Yes: 8550
Chemo Therapy	3915	0.95	FALSE	4	No: 31084, Yes: 29672, Unk: 12595, #!N: 5
Hormonal Therapy	4045	0.95	FALSE	3	No: 47828, Unk: 21311, Yes: 4087
Symptoms	202	1.00	FALSE	4	Yes: 76447, No: 445, Unk: 175, #!N: 2
Mortality Status	1020	0.99	FALSE	2	Ali: 55497, Dea: 20754
Cause of Death	72794	0.06	FALSE	3	Can: 4381, Unk: 59, Oth: 37
Concurrent Illness	1305	0.98	FALSE	4	Unk: 57864, ABS: 11730, PRE: 6371, #!N: 1
Primary Site	0	1.00	FALSE	60	BLO: 8640, BRE: 7928, CER: 7779, ESO: 6719
Age Group	786	0.99	FALSE	16	60-: 6983, 55-: 6937, 40-: 6747, 50-: 6576

Variable type: logical

skim_variable	n_missing	complete_rate	mean	count
MPCODE	77271	0	NaN	:

Variable type: numeric

skim_variable	n_missing	complete_rate	mean	sd	p0	p25	p50	p75	p100	hist
SOURCERECORDID	21	1.00	2.014457e+13	5.544472e+10	1.987000e+13	2.012104e+13	2.016168e+13	2.018341e+13	2.021182e+13	▁▁▁▃▇
AGE	0	1.00	4.682000e+01	2.285000e+01	-1.000000e+00	3.300000e+01	4.900000e+01	6.300000e+01	9.990000e+02	▇▁▁▁▁
INCID	203	1.00	2.014201e+07	1.812936e+05	2.010110e+06	2.012082e+07	2.016073e+07	2.018092e+07	2.020122e+07	▁▁▁▁▇
HISTO	70	1.00	8.588660e+03	6.653400e+02	8.000000e+03	8.070000e+03	8.140000e+03	9.140000e+03	9.989000e+03	▇▂▂▁▂
BEHA	42	1.00	3.000000e+00	6.000000e-02	0.000000e+00	3.000000e+00	3.000000e+00	3.000000e+00	3.000000e+00	▁▁▁▁▇
GRADE	6766	0.91	6.890000e+00	3.190000e+00	1.000000e+00	3.000000e+00	9.000000e+00	9.000000e+00	9.000000e+00	▂▁▁▁▇
BASIS	64	1.00	6.250000e+00	1.660000e+00	0.000000e+00	7.000000e+00	7.000000e+00	7.000000e+00	9.000000e+00	▁▁▂▇▁
STAGE	29624	0.62	6.480000e+00	2.910000e+00	0.000000e+00	4.000000e+00	9.000000e+00	9.000000e+00	9.000000e+00	▁▂▃▁▇
SURG	3990	0.95	3.240000e+00	3.430000e+00	1.000000e+00	1.000000e+00	1.000000e+00	9.000000e+00	9.000000e+00	▇▁▁▁▃
RADIO	4033	0.95	3.310000e+00	3.510000e+00	1.000000e+00	1.000000e+00	1.000000e+00	9.000000e+00	9.000000e+00	▇▁▁▁▃
CHEMO	3915	0.95	2.780000e+00	2.870000e+00	1.000000e+00	1.000000e+00	2.000000e+00	2.000000e+00	9.000000e+00	▇▁▁▁▂
HORMONE	4045	0.95	3.380000e+00	3.610000e+00	1.000000e+00	1.000000e+00	1.000000e+00	9.000000e+00	9.000000e+00	▇▁▁▁▃
SYMPT	202	1.00	2.010000e+00	3.400000e-01	0.000000e+00	2.000000e+00	2.000000e+00	2.000000e+00	9.000000e+00	▁▇▁▁▁
REGNO_	21	1.00	2.014433e+07	8.563807e+04	2.002853e+06	2.012104e+07	2.016168e+07	2.018341e+07	2.021182e+07	▁▁▁▁▇
SEX	1	1.00	1.530000e+00	5.000000e-01	1.000000e+00	1.000000e+00	2.000000e+00	2.000000e+00	2.000000e+00	▇▁▁▁▇
CONC_ILL	1305	0.98	7.250000e+00	3.140000e+00	1.000000e+00	9.000000e+00	9.000000e+00	9.000000e+00	9.000000e+00	▂▁▁▁▇
DATELAST	4064	0.95	2.014461e+07	5.475913e+05	0.000000e+00	2.013022e+07	2.017051e+07	2.019050e+07	1.000000e+08	▁▇▁▁▁
STATUS	1020	0.99	1.270000e+00	4.500000e-01	1.000000e+00	1.000000e+00	1.000000e+00	2.000000e+00	2.000000e+00	▇▁▁▁▃
CAUSE	72794	0.06	1.110000e+00	9.200000e-01	1.000000e+00	1.000000e+00	1.000000e+00	1.000000e+00	9.000000e+00	▇▁▁▁▁
PATIENTRECORDID	21	1.00	2.014433e+09	8.563798e+06	2.002853e+08	2.012104e+09	2.016168e+09	2.018341e+09	2.021182e+09	▁▁▁▁▇

5.1.2 DQA Report: Main Issues

This can’t be right? 77K casese between 2001 and 2005?

Date columns doesn’t look right, was it exported using different format?

Missing Dictionary for: ADRCODE: “041” “047” “052” “042” “001” “010” “032” “040” "070

Missing Dictionary for: HIST: “8692” “8821” “9766” “8822” “8077” “8472” “9340” “9537” “9975” “9300” “9970” “9421” “9352” “8507” “8870”

Missing Dictionary for: STAGE: 5, 7

Missing Dictionary for: CONC_ILL: 4

Missing Dictionary for: T: “+”

Missing Dictionary for: M: 9,4,2,3,X

Missing Dictionary for: SOURCE1: BV

Missing Dictionary for: TRIBE: 7, 48, 45, 31

Table X: Name of table
label	variable	Sex		Total
label	variable	Female	Male	Total
Age Group	0-4	1670 (46%)	1954 (54%)	3624 (5%)
	5-9	973 (40%)	1485 (60%)	2458 (3%)
	10-14	977 (39%)	1521 (61%)	2498 (3%)
	15-19	1055 (42%)	1437 (58%)	2492 (3%)
	20-24	1108 (52%)	1009 (48%)	2117 (3%)
	25-29	1669 (57%)	1252 (43%)	2921 (4%)
	30-34	2818 (60%)	1841 (40%)	4659 (6%)
	35-39	3396 (64%)	1923 (36%)	5319 (7%)
	40-44	4354 (65%)	2393 (35%)	6747 (9%)
	45-49	3802 (60%)	2497 (40%)	6299 (8%)
	50-54	3904 (59%)	2672 (41%)	6576 (9%)
	55-59	3860 (56%)	3077 (44%)	6937 (9%)
	60-64	3585 (51%)	3398 (49%)	6983 (9%)
	65-69	2698 (46%)	3198 (54%)	5896 (8%)
	70-74	2157 (43%)	2831 (57%)	4988 (7%)
	> 75	2420 (41%)	3551 (59%)	5971 (8%)
	Total	40446 (53%)	36039 (47%)	76485 (100%)

Table X: Name of table
label	variable	Sex		Total
label	variable	Female	Male	Total
ADRCODE	Ainabkoi	1154 (53%)	1024 (47%)	2178 (3%)
	Central	692 (55%)	560 (45%)	1252 (2%)
	KAPSARET	1278 (58%)	930 (42%)	2208 (3%)
	Kesses	836 (53%)	749 (47%)	1585 (2%)
	Moiben	1080 (51%)	1045 (49%)	2125 (3%)
	Soy	1362 (51%)	1300 (49%)	2662 (3%)
	TURBO	1495 (58%)	1079 (42%)	2574 (3%)
	Unknown	32879 (52%)	29807 (48%)	62686 (81%)
	Total	40776 (53%)	36494 (47%)	77270 (100%)

Table 1: General Summary Statistics \| Main Variables
		Sex
Variable	Overall, N = 77,2701	Female, N = 40,7761	Male, N = 36,4941	p-value2
AGE	46.8 (22.8)	46.3 (21.4)	47.4 (24.3)	<0.001
Behaviour				<0.001
Benign	4.0 (0.0%)	3.0 (0.0%)	1.0 (0.0%)
In situ	54.0 (0.1%)	42.0 (0.1%)	12.0 (0.0%)
Malignant	77,131.0 (99.9%)	40,695.0 (99.9%)	36,436.0 (99.9%)
Uncertain	40.0 (0.1%)	16.0 (0.0%)	24.0 (0.1%)
N/A	41	20	21
Basis of Diagnosis				<0.001
Autopsy with Histology	36.0 (0.0%)	21.0 (0.1%)	15.0 (0.0%)
Biochem./Immuno. test	372.0 (0.5%)	25.0 (0.1%)	347.0 (1.0%)
Clin.Invest./Ult.Sound	4,147.0 (5.4%)	1,980.0 (4.9%)	2,167.0 (5.9%)
Clinical only	759.0 (1.0%)	381.0 (0.9%)	378.0 (1.0%)
Cytology/Haemotology	10,434.0 (13.5%)	5,203.0 (12.8%)	5,231.0 (14.3%)
Death Certificate Only	1,613.0 (2.1%)	757.0 (1.9%)	856.0 (2.3%)
Histology metastases	109.0 (0.1%)	54.0 (0.1%)	55.0 (0.2%)
Histology of primary	59,423.0 (77.0%)	32,155.0 (78.9%)	27,268.0 (74.8%)
Surgery/Autopsy	34.0 (0.0%)	16.0 (0.0%)	18.0 (0.0%)
Unknown	280.0 (0.4%)	146.0 (0.4%)	134.0 (0.4%)
N/A	63	38	25
Stage				<0.001
#!NoDict	10.0 (0.0%)	10.0 (0.0%)	0.0 (0.0%)
In Situ	28.0 (0.1%)	20.0 (0.1%)	8.0 (0.0%)
Stage I	1,345.0 (2.8%)	1,187.0 (4.6%)	158.0 (0.7%)
Stage II	2,606.0 (5.5%)	2,183.0 (8.4%)	423.0 (2.0%)
Stage III	5,833.0 (12.2%)	4,586.0 (17.7%)	1,247.0 (5.8%)
Stage IV	11,193.0 (23.5%)	5,655.0 (21.8%)	5,538.0 (25.6%)
Unknown	26,632.0 (55.9%)	12,332.0 (47.5%)	14,300.0 (66.0%)
N/A	29,623	14,803	14,820
Grade				<0.001
B-cell	15.0 (0.0%)	0.0 (0.0%)	15.0 (0.0%)
Grade I: Well diff.	4,387.0 (6.2%)	2,454.0 (6.5%)	1,933.0 (5.9%)
Grade II: Mod. diff.	9,860.0 (14.0%)	6,490.0 (17.3%)	3,370.0 (10.2%)
Grade III: Poor diff.	7,040.0 (10.0%)	4,655.0 (12.4%)	2,385.0 (7.2%)
Grade IV: Undiff./Anap.	501.0 (0.7%)	183.0 (0.5%)	318.0 (1.0%)
Killer cell	7.0 (0.0%)	1.0 (0.0%)	6.0 (0.0%)
Null cell	4.0 (0.0%)	2.0 (0.0%)	2.0 (0.0%)
T-cell	11.0 (0.0%)	7.0 (0.0%)	4.0 (0.0%)
Unknown	48,680.0 (69.0%)	23,740.0 (63.3%)	24,940.0 (75.6%)
N/A	6,765	3,244	3,521
Surgery				<0.001
No	42,280.0 (57.7%)	20,988.0 (54.4%)	21,292.0 (61.4%)
Unknown	19,053.0 (26.0%)	9,951.0 (25.8%)	9,102.0 (26.2%)
Yes	11,948.0 (16.3%)	7,655.0 (19.8%)	4,293.0 (12.4%)
N/A	3,989	2,182	1,807
Radio Therapy				<0.001
No	44,575.0 (60.9%)	22,760.0 (59.0%)	21,815.0 (62.9%)
Unknown	20,113.0 (27.5%)	10,921.0 (28.3%)	9,192.0 (26.5%)
Yes	8,550.0 (11.7%)	4,881.0 (12.7%)	3,669.0 (10.6%)
N/A	4,032	2,214	1,818
Chemo Therapy				<0.001
#!NoDict	5.0 (0.0%)	2.0 (0.0%)	3.0 (0.0%)
No	31,084.0 (42.4%)	15,555.0 (40.3%)	15,529.0 (44.7%)
Unknown	12,595.0 (17.2%)	6,729.0 (17.4%)	5,866.0 (16.9%)
Yes	29,672.0 (40.4%)	16,345.0 (42.3%)	13,327.0 (38.4%)
N/A	3,914	2,145	1,769
Hormonal Therapy				<0.001
No	47,828.0 (65.3%)	24,891.0 (64.6%)	22,937.0 (66.1%)
Unknown	21,311.0 (29.1%)	11,966.0 (31.0%)	9,345.0 (26.9%)
Yes	4,087.0 (5.6%)	1,688.0 (4.4%)	2,399.0 (6.9%)
N/A	4,044	2,231	1,813
Symptoms				0.5
#!NoDict	2.0 (0.0%)	0.0 (0.0%)	2.0 (0.0%)
No	445.0 (0.6%)	244.0 (0.6%)	201.0 (0.6%)
Unknown	175.0 (0.2%)	91.0 (0.2%)	84.0 (0.2%)
Yes	76,447.0 (99.2%)	40,321.0 (99.2%)	36,126.0 (99.2%)
N/A	201	120	81
Mortality Status				<0.001
Alive	55,497.0 (72.8%)	29,753.0 (73.9%)	25,744.0 (71.5%)
Dead	20,754.0 (27.2%)	10,481.0 (26.1%)	10,273.0 (28.5%)
N/A	1,019	542	477
Cause of Death				0.017
Cancer	4,381.0 (97.9%)	2,080.0 (97.6%)	2,301.0 (98.1%)
Other	37.0 (0.8%)	14.0 (0.7%)	23.0 (1.0%)
Unknown	59.0 (1.3%)	38.0 (1.8%)	21.0 (0.9%)
N/A	72,793	38,644	34,149
Concurrent Illness				<0.001
#!NoDict	1.0 (0.0%)	0.0 (0.0%)	1.0 (0.0%)
ABSENT	11,730.0 (15.4%)	6,913.0 (17.2%)	4,817.0 (13.4%)
PRESENT	6,371.0 (8.4%)	3,508.0 (8.8%)	2,863.0 (8.0%)
Unknown	57,864.0 (76.2%)	29,658.0 (74.0%)	28,206.0 (78.6%)
N/A	1,304	697	607
T				<0.001
#!NoDict	2.0 (0.0%)	0.0 (0.0%)	2.0 (0.1%)
Adv.	277.0 (4.8%)	147.0 (3.9%)	130.0 (6.7%)
Loc.	135.0 (2.4%)	62.0 (1.6%)	73.0 (3.7%)
T1	488.0 (8.5%)	388.0 (10.3%)	100.0 (5.1%)
T2	1,417.0 (24.7%)	954.0 (25.3%)	463.0 (23.7%)
T3	1,765.0 (30.8%)	1,176.0 (31.1%)	589.0 (30.1%)
T4	1,582.0 (27.6%)	1,005.0 (26.6%)	577.0 (29.5%)
To	65.0 (1.1%)	45.0 (1.2%)	20.0 (1.0%)
N/A	71,539	36,999	34,540
M				<0.001
#!NoDict	334.0 (5.9%)	171.0 (4.7%)	163.0 (8.1%)
M+	1,704.0 (30.1%)	1,149.0 (31.4%)	555.0 (27.6%)
M0	3,188.0 (56.2%)	2,054.0 (56.1%)	1,134.0 (56.4%)
M1	444.0 (7.8%)	286.0 (7.8%)	158.0 (7.9%)
N/A	71,600	37,116	34,484
ADRCODE				<0.001
Ainabkoi	2,178.0 (2.8%)	1,154.0 (2.8%)	1,024.0 (2.8%)
Central	1,252.0 (1.6%)	692.0 (1.7%)	560.0 (1.5%)
KAPSARET	2,208.0 (2.9%)	1,278.0 (3.1%)	930.0 (2.5%)
Kesses	1,585.0 (2.1%)	836.0 (2.1%)	749.0 (2.1%)
Moiben	2,125.0 (2.8%)	1,080.0 (2.6%)	1,045.0 (2.9%)
Soy	2,662.0 (3.4%)	1,362.0 (3.3%)	1,300.0 (3.6%)
TURBO	2,574.0 (3.3%)	1,495.0 (3.7%)	1,079.0 (3.0%)
Unknown	62,686.0 (81.1%)	32,879.0 (80.6%)	29,807.0 (81.7%)
1Mean (SD); n (%)
2Wilcoxon rank sum test; Fisher's Exact Test for Count Data with simulated p-value (based on 2000 replicates); Pearson's Chi-squared test

Table 2: General Summary Statistics \| Morphology
		Sex
Variable	Overall, N = 77,2701	Female, N = 40,7761	Male, N = 36,4941	p-value2
Primary Site				<0.001
ACCESSORY SINUSES	201.0 (0.3%)	81.0 (0.2%)	120.0 (0.3%)
ADRENAL GLAND	60.0 (0.1%)	32.0 (0.1%)	28.0 (0.1%)
ANUS, ANAL CANAL	309.0 (0.4%)	168.0 (0.4%)	141.0 (0.4%)
BILE TRACT	43.0 (0.1%)	30.0 (0.1%)	13.0 (0.0%)
BLADDER	526.0 (0.7%)	156.0 (0.4%)	370.0 (1.0%)
BLOOD, SPLEEN	8,639.0 (11.2%)	3,846.0 (9.4%)	4,793.0 (13.1%)
BONES - LIMBS	618.0 (0.8%)	274.0 (0.7%)	344.0 (0.9%)
BONES - OTHER	691.0 (0.9%)	295.0 (0.7%)	396.0 (1.1%)
BRAIN	1,011.0 (1.3%)	410.0 (1.0%)	601.0 (1.6%)
BREAST	7,928.0 (10.3%)	7,470.0 (18.3%)	458.0 (1.3%)
BRONCHUS, LUNG	1,245.0 (1.6%)	573.0 (1.4%)	672.0 (1.8%)
CERVIX UTERI	7,779.0 (10.1%)	7,777.0 (19.1%)	2.0 (0.0%)
COLON	1,774.0 (2.3%)	794.0 (1.9%)	980.0 (2.7%)
CORPUS UTERI	676.0 (0.9%)	676.0 (1.7%)	0.0 (0.0%)
EAR/NOSE	80.0 (0.1%)	32.0 (0.1%)	48.0 (0.1%)
ENDOCRINE GLANDS	38.0 (0.0%)	16.0 (0.0%)	22.0 (0.1%)
ESOPHAGUS	6,719.0 (8.7%)	2,491.0 (6.1%)	4,228.0 (11.6%)
EYE	952.0 (1.2%)	456.0 (1.1%)	496.0 (1.4%)
FEMALE GEN.- OTHER	15.0 (0.0%)	15.0 (0.0%)	0.0 (0.0%)
GALL BLADDER	194.0 (0.3%)	137.0 (0.3%)	57.0 (0.2%)
GASTROINTESTINAL	72.0 (0.1%)	23.0 (0.1%)	49.0 (0.1%)
HEART, PLEURA	115.0 (0.1%)	43.0 (0.1%)	72.0 (0.2%)
HYPOPHARYNX	192.0 (0.2%)	70.0 (0.2%)	122.0 (0.3%)
ILL-DEFINED	1,168.0 (1.5%)	518.0 (1.3%)	650.0 (1.8%)
KIDNEY	1,196.0 (1.5%)	530.0 (1.3%)	666.0 (1.8%)
LARYNX	570.0 (0.7%)	96.0 (0.2%)	474.0 (1.3%)
LIVER	2,102.0 (2.7%)	836.0 (2.1%)	1,266.0 (3.5%)
LYMPH NODES	4,964.0 (6.4%)	1,815.0 (4.5%)	3,149.0 (8.6%)
MALE GEN.- OTHER	31.0 (0.0%)	4.0 (0.0%)	27.0 (0.1%)
MENINGES	56.0 (0.1%)	38.0 (0.1%)	18.0 (0.0%)
NASOPHARYNX	1,996.0 (2.6%)	676.0 (1.7%)	1,320.0 (3.6%)
NERVOUS SYSTEM	35.0 (0.0%)	16.0 (0.0%)	19.0 (0.1%)
OROPHARYNX	131.0 (0.2%)	40.0 (0.1%)	91.0 (0.2%)
OTHER	2,060.0 (2.7%)	942.0 (2.3%)	1,118.0 (3.1%)
OTHER PHARYNX	122.0 (0.2%)	25.0 (0.1%)	97.0 (0.3%)
OVARY	1,477.0 (1.9%)	1,477.0 (3.6%)	0.0 (0.0%)
PANCREAS	1,120.0 (1.4%)	542.0 (1.3%)	578.0 (1.6%)
PENIS	205.0 (0.3%)	0.0 (0.0%)	205.0 (0.6%)
PERIPHERAL NERVES	28.0 (0.0%)	12.0 (0.0%)	16.0 (0.0%)
PERITONEUM	134.0 (0.2%)	69.0 (0.2%)	65.0 (0.2%)
PLACENTA	125.0 (0.2%)	125.0 (0.3%)	0.0 (0.0%)
PROSTATE	4,281.0 (5.5%)	7.0 (0.0%)	4,274.0 (11.7%)
PYRIFORM SINUS	1.0 (0.0%)	0.0 (0.0%)	1.0 (0.0%)
RECTOSIGMOID JTN	296.0 (0.4%)	140.0 (0.3%)	156.0 (0.4%)
RECTUM	1,188.0 (1.5%)	517.0 (1.3%)	671.0 (1.8%)
RENAL PELVIS	11.0 (0.0%)	6.0 (0.0%)	5.0 (0.0%)
RESPIRATORY TRACT	4.0 (0.0%)	4.0 (0.0%)	0.0 (0.0%)
SKIN	6,159.0 (8.0%)	2,496.0 (6.1%)	3,663.0 (10.0%)
SMALL INTESTINE	120.0 (0.2%)	35.0 (0.1%)	85.0 (0.2%)
SOFT TISSUES	1,358.0 (1.8%)	631.0 (1.5%)	727.0 (2.0%)
STOMACH	2,420.0 (3.1%)	907.0 (2.2%)	1,513.0 (4.1%)
TESTIS	100.0 (0.1%)	0.0 (0.0%)	100.0 (0.3%)
THYMUS	9.0 (0.0%)	0.0 (0.0%)	9.0 (0.0%)
THYROID	731.0 (0.9%)	533.0 (1.3%)	198.0 (0.5%)
TRACHEA	7.0 (0.0%)	3.0 (0.0%)	4.0 (0.0%)
UNKNOWN	2,443.0 (3.2%)	1,145.0 (2.8%)	1,298.0 (3.6%)
URETHRA, OTHER	30.0 (0.0%)	11.0 (0.0%)	19.0 (0.1%)
UTERUS, NOS	253.0 (0.3%)	253.0 (0.6%)	0.0 (0.0%)
VAGINA	83.0 (0.1%)	83.0 (0.2%)	0.0 (0.0%)
VULVA	379.0 (0.5%)	379.0 (0.9%)	0.0 (0.0%)
1n (%)
2Fisher's Exact Test for Count Data with simulated p-value (based on 2000 replicates)

Table X: Name of table
label	variable	Age Group																Total
label	variable	0-4	5-9	10-14	15-19	20-24	25-29	30-34	35-39	40-44	45-49	50-54	55-59	60-64	65-69	70-74	> 75	Total
Primary Site	ACCESSORY SINUSES	14 (7%)	9 (5%)	5 (3%)	8 (4%)	9 (5%)	12 (6%)	8 (4%)	9 (5%)	15 (8%)	25 (13%)	18 (9%)	14 (7%)	30 (15%)	13 (7%)	6 (3%)	2 (1%)	197 (0.3%)
	ADRENAL GLAND	14 (23%)	9 (15%)	6 (10%)	7 (12%)	4 (7%)	4 (7%)	5 (8%)	3 (5%)	0 (0%)	5 (8%)	3 (5%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	60 (0.08%)
	ANUS, ANAL CANAL	2 (1%)	0 (0%)	0 (0%)	1 (0.3%)	6 (2%)	21 (7%)	21 (7%)	25 (8%)	35 (11%)	33 (11%)	34 (11%)	39 (13%)	34 (11%)	21 (7%)	20 (6%)	17 (6%)	309 (0.4%)
	BILE TRACT	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	1 (2%)	0 (0%)	1 (2%)	0 (0%)	4 (9%)	4 (9%)	5 (12%)	2 (5%)	8 (19%)	14 (33%)	4 (9%)	43 (0.06%)
	BLADDER	18 (4%)	0 (0%)	5 (1%)	0 (0%)	6 (1%)	3 (1%)	9 (2%)	12 (2%)	37 (7%)	23 (5%)	39 (8%)	59 (12%)	84 (17%)	81 (16%)	68 (13%)	65 (13%)	509 (1%)
	BLOOD, SPLEEN	618 (7%)	725 (8%)	755 (9%)	511 (6%)	376 (4%)	429 (5%)	489 (6%)	383 (4%)	482 (6%)	540 (6%)	609 (7%)	682 (8%)	639 (7%)	541 (6%)	371 (4%)	439 (5%)	8589 (11%)
	BONES - LIMBS	15 (2%)	40 (6%)	139 (23%)	190 (31%)	60 (10%)	16 (3%)	29 (5%)	29 (5%)	20 (3%)	17 (3%)	20 (3%)	8 (1%)	10 (2%)	8 (1%)	9 (1%)	7 (1%)	617 (1%)
	BONES - OTHER	33 (5%)	28 (4%)	86 (13%)	131 (19%)	63 (9%)	30 (4%)	42 (6%)	38 (6%)	26 (4%)	30 (4%)	35 (5%)	30 (4%)	35 (5%)	23 (3%)	20 (3%)	32 (5%)	682 (1%)
	BRAIN	75 (7%)	87 (9%)	74 (7%)	51 (5%)	57 (6%)	48 (5%)	73 (7%)	65 (6%)	67 (7%)	56 (6%)	106 (11%)	81 (8%)	63 (6%)	52 (5%)	30 (3%)	22 (2%)	1007 (1%)
	BREAST	74 (1%)	0 (0%)	7 (0.09%)	36 (0.5%)	112 (1%)	281 (4%)	609 (8%)	943 (12%)	1194 (15%)	999 (13%)	926 (12%)	742 (9%)	739 (9%)	461 (6%)	338 (4%)	406 (5%)	7867 (10%)
	BRONCHUS, LUNG	36 (3%)	0 (0%)	2 (0.2%)	5 (0.4%)	8 (1%)	24 (2%)	37 (3%)	50 (4%)	83 (7%)	90 (7%)	123 (10%)	200 (16%)	159 (13%)	136 (11%)	145 (12%)	128 (10%)	1226 (2%)
	CERVIX UTERI	98 (1%)	2 (0.03%)	0 (0%)	21 (0.3%)	57 (1%)	240 (3%)	495 (6%)	824 (11%)	1184 (15%)	1020 (13%)	971 (13%)	905 (12%)	738 (10%)	456 (6%)	381 (5%)	322 (4%)	7714 (10%)
	COLON	32 (2%)	0 (0%)	4 (0.2%)	35 (2%)	43 (2%)	64 (4%)	122 (7%)	100 (6%)	142 (8%)	154 (9%)	191 (11%)	212 (12%)	212 (12%)	146 (8%)	141 (8%)	152 (9%)	1750 (2%)
	CORPUS UTERI	17 (3%)	0 (0%)	2 (0.3%)	5 (1%)	2 (0.3%)	6 (1%)	18 (3%)	14 (2%)	46 (7%)	44 (7%)	66 (10%)	107 (16%)	137 (21%)	80 (12%)	71 (11%)	47 (7%)	662 (1%)
	EAR/NOSE	2 (3%)	0 (0%)	0 (0%)	6 (8%)	6 (8%)	6 (8%)	4 (5%)	12 (15%)	16 (21%)	2 (3%)	6 (8%)	4 (5%)	7 (9%)	2 (3%)	2 (3%)	3 (4%)	78 (0.1%)
	ENDOCRINE GLANDS	0 (0%)	1 (3%)	1 (3%)	0 (0%)	2 (5%)	3 (8%)	4 (11%)	10 (26%)	1 (3%)	2 (5%)	2 (5%)	1 (3%)	2 (5%)	7 (18%)	2 (5%)	0 (0%)	38 (0.05%)
	ESOPHAGUS	175 (3%)	2 (0.03%)	0 (0%)	21 (0.3%)	45 (1%)	121 (2%)	169 (3%)	249 (4%)	396 (6%)	622 (9%)	702 (11%)	895 (14%)	897 (14%)	809 (12%)	746 (11%)	773 (12%)	6622 (9%)
	EYE	400 (42%)	96 (10%)	27 (3%)	10 (1%)	12 (1%)	19 (2%)	53 (6%)	62 (7%)	87 (9%)	52 (5%)	37 (4%)	15 (2%)	29 (3%)	25 (3%)	17 (2%)	11 (1%)	952 (1%)
	FEMALE GEN.- OTHER	2 (13%)	0 (0%)	2 (13%)	3 (20%)	0 (0%)	1 (7%)	2 (13%)	0 (0%)	2 (13%)	0 (0%)	0 (0%)	3 (20%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	15 (0.02%)
	GALL BLADDER	5 (3%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	4 (2%)	5 (3%)	14 (7%)	13 (7%)	40 (21%)	35 (18%)	20 (10%)	24 (12%)	17 (9%)	17 (9%)	194 (0.3%)
	GASTROINTESTINAL	1 (1%)	1 (1%)	1 (1%)	3 (4%)	6 (8%)	0 (0%)	0 (0%)	9 (12%)	6 (8%)	5 (7%)	1 (1%)	12 (17%)	2 (3%)	14 (19%)	9 (12%)	2 (3%)	72 (0.09%)
	HEART, PLEURA	2 (2%)	3 (3%)	13 (12%)	9 (8%)	4 (4%)	6 (5%)	4 (4%)	13 (12%)	8 (7%)	11 (10%)	7 (6%)	10 (9%)	2 (2%)	7 (6%)	8 (7%)	3 (3%)	110 (0.1%)
	HYPOPHARYNX	5 (3%)	0 (0%)	2 (1%)	20 (11%)	10 (5%)	11 (6%)	11 (6%)	9 (5%)	14 (8%)	14 (8%)	18 (10%)	14 (8%)	29 (16%)	7 (4%)	8 (4%)	13 (7%)	185 (0.2%)
	ILL-DEFINED	149 (13%)	191 (17%)	123 (11%)	57 (5%)	50 (4%)	49 (4%)	74 (6%)	54 (5%)	64 (6%)	52 (5%)	48 (4%)	66 (6%)	69 (6%)	35 (3%)	36 (3%)	38 (3%)	1155 (2%)
	KIDNEY	550 (46%)	248 (21%)	51 (4%)	19 (2%)	8 (1%)	14 (1%)	19 (2%)	25 (2%)	39 (3%)	31 (3%)	35 (3%)	50 (4%)	19 (2%)	54 (5%)	11 (1%)	20 (2%)	1193 (2%)
	LARYNX	8 (1%)	0 (0%)	0 (0%)	4 (1%)	12 (2%)	0 (0%)	10 (2%)	28 (5%)	27 (5%)	33 (6%)	75 (13%)	74 (13%)	120 (21%)	58 (10%)	71 (13%)	43 (8%)	563 (1%)
	LIVER	60 (3%)	10 (0.5%)	21 (1%)	29 (1%)	60 (3%)	55 (3%)	151 (7%)	203 (10%)	201 (10%)	216 (10%)	198 (10%)	240 (12%)	187 (9%)	147 (7%)	125 (6%)	180 (9%)	2083 (3%)
	LYMPH NODES	452 (9%)	681 (14%)	679 (14%)	504 (10%)	260 (5%)	237 (5%)	296 (6%)	272 (6%)	335 (7%)	259 (5%)	242 (5%)	212 (4%)	174 (4%)	128 (3%)	103 (2%)	103 (2%)	4937 (6%)
	MALE GEN.- OTHER	2 (6%)	2 (6%)	0 (0%)	0 (0%)	2 (6%)	0 (0%)	3 (10%)	3 (10%)	2 (6%)	0 (0%)	8 (26%)	0 (0%)	3 (10%)	2 (6%)	2 (6%)	2 (6%)	31 (0.04%)
	MENINGES	2 (4%)	0 (0%)	0 (0%)	1 (2%)	2 (4%)	2 (4%)	6 (11%)	7 (12%)	5 (9%)	6 (11%)	3 (5%)	7 (12%)	5 (9%)	4 (7%)	5 (9%)	1 (2%)	56 (0.07%)
	NASOPHARYNX	34 (2%)	22 (1%)	137 (7%)	228 (11%)	177 (9%)	124 (6%)	141 (7%)	133 (7%)	172 (9%)	165 (8%)	185 (9%)	125 (6%)	150 (8%)	105 (5%)	47 (2%)	45 (2%)	1990 (3%)
	NERVOUS SYSTEM	1 (3%)	3 (9%)	3 (9%)	4 (11%)	0 (0%)	1 (3%)	1 (3%)	7 (20%)	5 (14%)	5 (14%)	0 (0%)	2 (6%)	2 (6%)	0 (0%)	0 (0%)	1 (3%)	35 (0.05%)
	OROPHARYNX	0 (0%)	0 (0%)	1 (1%)	5 (4%)	6 (5%)	7 (5%)	4 (3%)	6 (5%)	22 (17%)	14 (11%)	7 (5%)	10 (8%)	16 (12%)	19 (15%)	9 (7%)	5 (4%)	131 (0.2%)
	OTHER	178 (9%)	40 (2%)	35 (2%)	35 (2%)	33 (2%)	80 (4%)	103 (5%)	98 (5%)	198 (10%)	220 (11%)	166 (8%)	191 (9%)	191 (9%)	161 (8%)	138 (7%)	161 (8%)	2028 (3%)
	OTHER PHARYNX	1 (1%)	0 (0%)	2 (2%)	4 (3%)	1 (1%)	9 (8%)	3 (3%)	3 (3%)	15 (13%)	12 (10%)	26 (22%)	15 (13%)	8 (7%)	10 (8%)	5 (4%)	5 (4%)	119 (0.2%)
	OVARY	20 (1%)	8 (1%)	39 (3%)	67 (5%)	58 (4%)	75 (5%)	86 (6%)	109 (7%)	157 (11%)	123 (8%)	144 (10%)	178 (12%)	135 (9%)	128 (9%)	59 (4%)	83 (6%)	1469 (2%)
	PANCREAS	18 (2%)	0 (0%)	1 (0.09%)	2 (0.2%)	8 (1%)	3 (0.3%)	32 (3%)	43 (4%)	71 (6%)	96 (9%)	88 (8%)	122 (11%)	146 (13%)	163 (15%)	143 (13%)	157 (14%)	1093 (1%)
	PENIS	2 (1%)	0 (0%)	0 (0%)	0 (0%)	1 (0.5%)	0 (0%)	13 (6%)	20 (10%)	20 (10%)	35 (17%)	19 (9%)	25 (12%)	8 (4%)	25 (12%)	22 (11%)	14 (7%)	204 (0.3%)
	PERIPHERAL NERVES	6 (21%)	3 (11%)	2 (7%)	1 (4%)	1 (4%)	1 (4%)	2 (7%)	0 (0%)	1 (4%)	4 (14%)	0 (0%)	3 (11%)	0 (0%)	0 (0%)	4 (14%)	0 (0%)	28 (0.04%)
	PERITONEUM	21 (16%)	11 (8%)	14 (10%)	10 (7%)	5 (4%)	3 (2%)	4 (3%)	2 (1%)	8 (6%)	5 (4%)	12 (9%)	10 (7%)	12 (9%)	7 (5%)	4 (3%)	6 (4%)	134 (0.2%)
	PLACENTA	0 (0%)	0 (0%)	0 (0%)	6 (5%)	33 (26%)	16 (13%)	34 (27%)	5 (4%)	22 (18%)	5 (4%)	3 (2%)	1 (1%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	125 (0.2%)
	PROSTATE	48 (1%)	2 (0.05%)	1 (0.02%)	4 (0.1%)	3 (0.07%)	2 (0.05%)	6 (0.1%)	4 (0.1%)	12 (0.3%)	47 (1%)	90 (2%)	305 (7%)	594 (14%)	830 (20%)	924 (22%)	1270 (31%)	4142 (5%)
	PYRIFORM SINUS	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	1 (100%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	1 (0.001%)
	RECTOSIGMOID JTN	1 (0.3%)	0 (0%)	0 (0%)	7 (2%)	4 (1%)	2 (1%)	12 (4%)	41 (14%)	29 (10%)	24 (8%)	36 (12%)	39 (13%)	35 (12%)	20 (7%)	28 (10%)	12 (4%)	290 (0.4%)
	RECTUM	13 (1%)	0 (0%)	0 (0%)	17 (1%)	26 (2%)	56 (5%)	93 (8%)	85 (7%)	137 (12%)	87 (7%)	124 (11%)	117 (10%)	129 (11%)	135 (11%)	61 (5%)	97 (8%)	1177 (2%)
	RENAL PELVIS	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	8 (73%)	0 (0%)	2 (18%)	0 (0%)	1 (9%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	11 (0.01%)
	RESPIRATORY TRACT	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	1 (25%)	0 (0%)	0 (0%)	0 (0%)	1 (25%)	0 (0%)	2 (50%)	4 (0.005%)
	SKIN	98 (2%)	81 (1%)	96 (2%)	140 (2%)	219 (4%)	572 (9%)	937 (15%)	837 (14%)	749 (12%)	547 (9%)	434 (7%)	386 (6%)	312 (5%)	238 (4%)	192 (3%)	288 (5%)	6126 (8%)
	SMALL INTESTINE	0 (0%)	1 (1%)	0 (0%)	1 (1%)	6 (5%)	4 (3%)	7 (6%)	4 (3%)	16 (14%)	19 (16%)	14 (12%)	10 (9%)	14 (12%)	13 (11%)	0 (0%)	8 (7%)	117 (0.2%)
	SOFT TISSUES	155 (11%)	104 (8%)	100 (7%)	148 (11%)	103 (8%)	84 (6%)	107 (8%)	87 (6%)	76 (6%)	84 (6%)	57 (4%)	62 (5%)	59 (4%)	52 (4%)	37 (3%)	41 (3%)	1356 (2%)
	STOMACH	44 (2%)	0 (0%)	4 (0.2%)	10 (0.4%)	30 (1%)	23 (1%)	86 (4%)	127 (5%)	149 (6%)	158 (7%)	224 (9%)	236 (10%)	341 (14%)	288 (12%)	261 (11%)	402 (17%)	2383 (3%)
	TESTIS	8 (8%)	9 (9%)	0 (0%)	15 (15%)	10 (10%)	6 (6%)	7 (7%)	1 (1%)	12 (12%)	6 (6%)	3 (3%)	12 (12%)	3 (3%)	3 (3%)	0 (0%)	5 (5%)	100 (0.1%)
	THYMUS	0 (0%)	1 (11%)	0 (0%)	1 (11%)	0 (0%)	0 (0%)	1 (11%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	2 (22%)	0 (0%)	0 (0%)	4 (44%)	9 (0.01%)
	THYROID	23 (3%)	4 (1%)	5 (1%)	15 (2%)	24 (3%)	30 (4%)	44 (6%)	45 (6%)	76 (10%)	70 (10%)	103 (14%)	62 (8%)	74 (10%)	74 (10%)	37 (5%)	44 (6%)	730 (1%)
	TRACHEA	0 (0%)	3 (43%)	0 (0%)	0 (0%)	0 (0%)	4 (57%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	7 (0.009%)
	UNKNOWN	73 (3%)	27 (1%)	48 (2%)	80 (3%)	61 (3%)	82 (3%)	99 (4%)	124 (5%)	153 (6%)	143 (6%)	203 (8%)	217 (9%)	261 (11%)	226 (9%)	194 (8%)	424 (18%)	2415 (3%)
	URETHRA, OTHER	0 (0%)	3 (10%)	0 (0%)	0 (0%)	5 (17%)	1 (3%)	0 (0%)	3 (10%)	0 (0%)	4 (13%)	2 (7%)	3 (10%)	4 (13%)	2 (7%)	0 (0%)	3 (10%)	30 (0.04%)
	UTERUS, NOS	4 (2%)	0 (0%)	0 (0%)	3 (1%)	15 (6%)	13 (5%)	19 (8%)	27 (11%)	27 (11%)	15 (6%)	32 (13%)	30 (12%)	10 (4%)	12 (5%)	26 (10%)	20 (8%)	253 (0.3%)
	VAGINA	7 (8%)	1 (1%)	0 (0%)	2 (2%)	0 (0%)	2 (2%)	11 (13%)	4 (5%)	8 (10%)	13 (16%)	6 (7%)	15 (18%)	1 (1%)	8 (10%)	5 (6%)	0 (0%)	83 (0.1%)
	VULVA	8 (2%)	0 (0%)	5 (1%)	0 (0%)	6 (2%)	18 (5%)	40 (11%)	39 (10%)	63 (17%)	37 (10%)	31 (8%)	38 (10%)	29 (8%)	27 (7%)	16 (4%)	22 (6%)	379 (0.5%)

Table x: Mortality Risk Factors
		Mortality Status
Variable	Overall, N = 76,2511	Alive, N = 55,4971	Dead, N = 20,7541	p-value2
Sex				<0.001
Female	40,234.0 (100.0%)	29,753.0 (73.9%)	10,481.0 (26.1%)
Male	36,017.0 (100.0%)	25,744.0 (71.5%)	10,273.0 (28.5%)
AGE	46.9 (22.6)	46.2 (22.8)	48.8 (22.0)	<0.001
Behaviour				<0.001
Benign	4.0 (100.0%)	2.0 (50.0%)	2.0 (50.0%)
In situ	54.0 (100.0%)	50.0 (92.6%)	4.0 (7.4%)
Malignant	76,138.0 (100.0%)	55,391.0 (72.8%)	20,747.0 (27.2%)
Uncertain	40.0 (100.0%)	39.0 (97.5%)	1.0 (2.5%)
N/A	15	15	0
Basis of Diagnosis				<0.001
Autopsy with Histology	36.0 (100.0%)	19.0 (52.8%)	17.0 (47.2%)
Biochem./Immuno. test	372.0 (100.0%)	264.0 (71.0%)	108.0 (29.0%)
Clin.Invest./Ult.Sound	4,122.0 (100.0%)	1,971.0 (47.8%)	2,151.0 (52.2%)
Clinical only	757.0 (100.0%)	490.0 (64.7%)	267.0 (35.3%)
Cytology/Haemotology	10,344.0 (100.0%)	7,322.0 (70.8%)	3,022.0 (29.2%)
Death Certificate Only	1,607.0 (100.0%)	20.0 (1.2%)	1,587.0 (98.8%)
Histology metastases	109.0 (100.0%)	88.0 (80.7%)	21.0 (19.3%)
Histology of primary	58,554.0 (100.0%)	45,084.0 (77.0%)	13,470.0 (23.0%)
Surgery/Autopsy	34.0 (100.0%)	18.0 (52.9%)	16.0 (47.1%)
Unknown	280.0 (100.0%)	186.0 (66.4%)	94.0 (33.6%)
N/A	36	35	1
Stage				<0.001
#!NoDict	10.0 (100.0%)	2.0 (20.0%)	8.0 (80.0%)
In Situ	28.0 (100.0%)	21.0 (75.0%)	7.0 (25.0%)
Stage I	1,345.0 (100.0%)	1,167.0 (86.8%)	178.0 (13.2%)
Stage II	2,600.0 (100.0%)	2,237.0 (86.0%)	363.0 (14.0%)
Stage III	5,824.0 (100.0%)	4,464.0 (76.6%)	1,360.0 (23.4%)
Stage IV	11,121.0 (100.0%)	7,235.0 (65.1%)	3,886.0 (34.9%)
Unknown	26,441.0 (100.0%)	19,129.0 (72.3%)	7,312.0 (27.7%)
N/A	28,882	21,242	7,640
Grade				<0.001
B-cell	15.0 (100.0%)	15.0 (100.0%)	0.0 (0.0%)
Grade I: Well diff.	4,324.0 (100.0%)	3,508.0 (81.1%)	816.0 (18.9%)
Grade II: Mod. diff.	9,741.0 (100.0%)	7,788.0 (80.0%)	1,953.0 (20.0%)
Grade III: Poor diff.	6,946.0 (100.0%)	5,351.0 (77.0%)	1,595.0 (23.0%)
Grade IV: Undiff./Anap.	485.0 (100.0%)	385.0 (79.4%)	100.0 (20.6%)
Killer cell	7.0 (100.0%)	5.0 (71.4%)	2.0 (28.6%)
Null cell	4.0 (100.0%)	3.0 (75.0%)	1.0 (25.0%)
T-cell	11.0 (100.0%)	11.0 (100.0%)	0.0 (0.0%)
Unknown	48,255.0 (100.0%)	33,785.0 (70.0%)	14,470.0 (30.0%)
N/A	6,463	4,646	1,817
Surgery				<0.001
No	42,116.0 (100.0%)	30,064.0 (71.4%)	12,052.0 (28.6%)
Unknown	19,015.0 (100.0%)	12,943.0 (68.1%)	6,072.0 (31.9%)
Yes	11,910.0 (100.0%)	9,473.0 (79.5%)	2,437.0 (20.5%)
N/A	3,210	3,017	193
Radio Therapy				<0.001
No	44,409.0 (100.0%)	32,025.0 (72.1%)	12,384.0 (27.9%)
Unknown	20,070.0 (100.0%)	13,949.0 (69.5%)	6,121.0 (30.5%)
Yes	8,542.0 (100.0%)	6,483.0 (75.9%)	2,059.0 (24.1%)
N/A	3,230	3,040	190
Chemo Therapy				<0.001
#!NoDict	5.0 (100.0%)	5.0 (100.0%)	0.0 (0.0%)
No	30,939.0 (100.0%)	21,733.0 (70.2%)	9,206.0 (29.8%)
Unknown	12,557.0 (100.0%)	8,170.0 (65.1%)	4,387.0 (34.9%)
Yes	29,636.0 (100.0%)	22,634.0 (76.4%)	7,002.0 (23.6%)
N/A	3,114	2,955	159
Hormonal Therapy				<0.001
No	47,655.0 (100.0%)	34,438.0 (72.3%)	13,217.0 (27.7%)
Unknown	21,266.0 (100.0%)	14,609.0 (68.7%)	6,657.0 (31.3%)
Yes	4,085.0 (100.0%)	3,407.0 (83.4%)	678.0 (16.6%)
N/A	3,245	3,043	202
Symptoms				<0.001
#!NoDict	2.0 (100.0%)	0.0 (0.0%)	2.0 (100.0%)
No	443.0 (100.0%)	249.0 (56.2%)	194.0 (43.8%)
Unknown	175.0 (100.0%)	58.0 (33.1%)	117.0 (66.9%)
Yes	75,472.0 (100.0%)	55,053.0 (72.9%)	20,419.0 (27.1%)
N/A	159	137	22
Cause of Death				0.018
Cancer	4,381.0 (100.0%)	42.0 (1.0%)	4,339.0 (99.0%)
Other	37.0 (100.0%)	2.0 (5.4%)	35.0 (94.6%)
Unknown	59.0 (100.0%)	0.0 (0.0%)	59.0 (100.0%)
N/A	71,774	55,453	16,321
Concurrent Illness				<0.001
#!NoDict	1.0 (100.0%)	1.0 (100.0%)	0.0 (0.0%)
ABSENT	11,694.0 (100.0%)	8,068.0 (69.0%)	3,626.0 (31.0%)
PRESENT	6,354.0 (100.0%)	4,824.0 (75.9%)	1,530.0 (24.1%)
Unknown	57,057.0 (100.0%)	41,774.0 (73.2%)	15,283.0 (26.8%)
N/A	1,145	830	315
T				<0.001
#!NoDict	2.0 (100.0%)	2.0 (100.0%)	0.0 (0.0%)
Adv.	277.0 (100.0%)	182.0 (65.7%)	95.0 (34.3%)
Loc.	135.0 (100.0%)	122.0 (90.4%)	13.0 (9.6%)
T1	488.0 (100.0%)	436.0 (89.3%)	52.0 (10.7%)
T2	1,416.0 (100.0%)	1,223.0 (86.4%)	193.0 (13.6%)
T3	1,761.0 (100.0%)	1,392.0 (79.0%)	369.0 (21.0%)
T4	1,575.0 (100.0%)	1,255.0 (79.7%)	320.0 (20.3%)
To	65.0 (100.0%)	54.0 (83.1%)	11.0 (16.9%)
N/A	70,532	50,831	19,701
M				<0.001
#!NoDict	334.0 (100.0%)	197.0 (59.0%)	137.0 (41.0%)
M+	1,696.0 (100.0%)	1,384.0 (81.6%)	312.0 (18.4%)
M0	3,188.0 (100.0%)	2,616.0 (82.1%)	572.0 (17.9%)
M1	444.0 (100.0%)	332.0 (74.8%)	112.0 (25.2%)
N/A	70,589	50,968	19,621
Primary Site				<0.001
ACCESSORY SINUSES	199.0 (100.0%)	139.0 (69.8%)	60.0 (30.2%)
ADRENAL GLAND	58.0 (100.0%)	55.0 (94.8%)	3.0 (5.2%)
ANUS, ANAL CANAL	309.0 (100.0%)	240.0 (77.7%)	69.0 (22.3%)
BILE TRACT	43.0 (100.0%)	25.0 (58.1%)	18.0 (41.9%)
BLADDER	520.0 (100.0%)	410.0 (78.8%)	110.0 (21.2%)
BLOOD, SPLEEN	8,561.0 (100.0%)	6,182.0 (72.2%)	2,379.0 (27.8%)
BONES - LIMBS	609.0 (100.0%)	490.0 (80.5%)	119.0 (19.5%)
BONES - OTHER	650.0 (100.0%)	496.0 (76.3%)	154.0 (23.7%)
BRAIN	979.0 (100.0%)	699.0 (71.4%)	280.0 (28.6%)
BREAST	7,855.0 (100.0%)	6,192.0 (78.8%)	1,663.0 (21.2%)
BRONCHUS, LUNG	1,227.0 (100.0%)	681.0 (55.5%)	546.0 (44.5%)
CERVIX UTERI	7,703.0 (100.0%)	5,917.0 (76.8%)	1,786.0 (23.2%)
COLON	1,755.0 (100.0%)	1,201.0 (68.4%)	554.0 (31.6%)
CORPUS UTERI	659.0 (100.0%)	539.0 (81.8%)	120.0 (18.2%)
EAR/NOSE	76.0 (100.0%)	67.0 (88.2%)	9.0 (11.8%)
ENDOCRINE GLANDS	38.0 (100.0%)	24.0 (63.2%)	14.0 (36.8%)
ESOPHAGUS	6,623.0 (100.0%)	4,319.0 (65.2%)	2,304.0 (34.8%)
EYE	932.0 (100.0%)	783.0 (84.0%)	149.0 (16.0%)
FEMALE GEN.- OTHER	15.0 (100.0%)	15.0 (100.0%)	0.0 (0.0%)
GALL BLADDER	190.0 (100.0%)	113.0 (59.5%)	77.0 (40.5%)
GASTROINTESTINAL	70.0 (100.0%)	63.0 (90.0%)	7.0 (10.0%)
HEART, PLEURA	109.0 (100.0%)	73.0 (67.0%)	36.0 (33.0%)
HYPOPHARYNX	188.0 (100.0%)	135.0 (71.8%)	53.0 (28.2%)
ILL-DEFINED	1,155.0 (100.0%)	867.0 (75.1%)	288.0 (24.9%)
KIDNEY	1,178.0 (100.0%)	903.0 (76.7%)	275.0 (23.3%)
LARYNX	562.0 (100.0%)	423.0 (75.3%)	139.0 (24.7%)
LIVER	2,067.0 (100.0%)	1,147.0 (55.5%)	920.0 (44.5%)
LYMPH NODES	4,917.0 (100.0%)	3,541.0 (72.0%)	1,376.0 (28.0%)
MALE GEN.- OTHER	29.0 (100.0%)	26.0 (89.7%)	3.0 (10.3%)
MENINGES	54.0 (100.0%)	43.0 (79.6%)	11.0 (20.4%)
NASOPHARYNX	1,965.0 (100.0%)	1,495.0 (76.1%)	470.0 (23.9%)
NERVOUS SYSTEM	35.0 (100.0%)	31.0 (88.6%)	4.0 (11.4%)
OROPHARYNX	131.0 (100.0%)	100.0 (76.3%)	31.0 (23.7%)
OTHER	2,005.0 (100.0%)	1,739.0 (86.7%)	266.0 (13.3%)
OTHER PHARYNX	122.0 (100.0%)	72.0 (59.0%)	50.0 (41.0%)
OVARY	1,460.0 (100.0%)	1,093.0 (74.9%)	367.0 (25.1%)
PANCREAS	1,098.0 (100.0%)	527.0 (48.0%)	571.0 (52.0%)
PENIS	201.0 (100.0%)	171.0 (85.1%)	30.0 (14.9%)
PERIPHERAL NERVES	26.0 (100.0%)	23.0 (88.5%)	3.0 (11.5%)
PERITONEUM	130.0 (100.0%)	104.0 (80.0%)	26.0 (20.0%)
PLACENTA	125.0 (100.0%)	85.0 (68.0%)	40.0 (32.0%)
PROSTATE	4,249.0 (100.0%)	3,131.0 (73.7%)	1,118.0 (26.3%)
PYRIFORM SINUS	1.0 (100.0%)	1.0 (100.0%)	0.0 (0.0%)
RECTOSIGMOID JTN	296.0 (100.0%)	190.0 (64.2%)	106.0 (35.8%)
RECTUM	1,175.0 (100.0%)	801.0 (68.2%)	374.0 (31.8%)
RENAL PELVIS	11.0 (100.0%)	5.0 (45.5%)	6.0 (54.5%)
RESPIRATORY TRACT	4.0 (100.0%)	3.0 (75.0%)	1.0 (25.0%)
SKIN	6,106.0 (100.0%)	5,100.0 (83.5%)	1,006.0 (16.5%)
SMALL INTESTINE	112.0 (100.0%)	93.0 (83.0%)	19.0 (17.0%)
SOFT TISSUES	1,330.0 (100.0%)	1,027.0 (77.2%)	303.0 (22.8%)
STOMACH	2,370.0 (100.0%)	1,590.0 (67.1%)	780.0 (32.9%)
TESTIS	96.0 (100.0%)	82.0 (85.4%)	14.0 (14.6%)
THYMUS	9.0 (100.0%)	5.0 (55.6%)	4.0 (44.4%)
THYROID	717.0 (100.0%)	601.0 (83.8%)	116.0 (16.2%)
TRACHEA	7.0 (100.0%)	3.0 (42.9%)	4.0 (57.1%)
UNKNOWN	2,414.0 (100.0%)	1,020.0 (42.3%)	1,394.0 (57.7%)
URETHRA, OTHER	28.0 (100.0%)	21.0 (75.0%)	7.0 (25.0%)
UTERUS, NOS	250.0 (100.0%)	188.0 (75.2%)	62.0 (24.8%)
VAGINA	79.0 (100.0%)	66.0 (83.5%)	13.0 (16.5%)
VULVA	369.0 (100.0%)	322.0 (87.3%)	47.0 (12.7%)
1n (%); Mean (SD)
2Pearson's Chi-squared test; Wilcoxon rank sum test; Fisher's Exact Test for Count Data with simulated p-value (based on 2000 replicates)

Table X: Name of table
Age Group	Female	Male	All	M/F	Proportion
0-4	1,670	1,954	3,624(0.05 %)	1.17	0.05
5-9	973	1,485	2,458(0.03 %)	1.53	0.03
10-14	977	1,521	2,498(0.03 %)	1.56	0.03
15-19	1,055	1,437	2,492(0.03 %)	1.36	0.03
20-24	1,108	1,009	2,117(0.03 %)	0.91	0.03
25-29	1,669	1,252	2,921(0.04 %)	0.75	0.04
30-34	2,818	1,841	4,659(0.06 %)	0.65	0.06
35-39	3,396	1,923	5,319(0.07 %)	0.57	0.07
40-44	4,354	2,393	6,747(0.09 %)	0.55	0.09
45-49	3,802	2,497	6,299(0.08 %)	0.66	0.08
50-54	3,904	2,672	6,576(0.09 %)	0.68	0.09
55-59	3,860	3,077	6,937(0.09 %)	0.80	0.09
60-64	3,585	3,398	6,983(0.09 %)	0.95	0.09
65-69	2,698	3,198	5,896(0.08 %)	1.19	0.08
70-74	2,157	2,831	4,988(0.07 %)	1.31	0.07
> 75	2,420	3,551	5,971(0.08 %)	1.47	0.08

Western Kenya Cancer Statistics

Western Kenya Cancer Statistics

Western Kenya Cancer Statistics

1 Background

2 Datasource

3 Study Population

4 Objective

5 Results for 2001 to 2005

5.1 Data Quality Assessment

5.1.1 DQA Summary Tables

5.1.2 DQA Report: Main Issues

5.2 Study Sample Analysis

5.2.1 Plots

5.2.2 Socio-Demographic Characteristics

5.2.3 Sub County distribution

5.3 General Summary Statistics

5.3.1 Main Covariates

5.3.2 Primary Cancer Site

5.3.3 Morphology

5.4 Main Analysis

5.4.1 Plot: Frequency and Proportions of the Most Common Cancer Types

5.4.2 Summary Table: : Frequency and Proportions of the Most Common Cancer Types

5.5 Mortality Analysis

5.5.1 Mortality Status

5.5.1.1 Plot

5.5.1.2 Summary Table | Age

5.5.2 Mortality Risk Factors

5.6 Clinical Factors Analysis

5.6.1 Clinical Summary

5.6.1.1 Plot: Cancer characteristics

5.6.1.2 Plot: Treatment

5.6.1.3 Summary table

5.6.2 Basis of Diagnosis Distribution

5.6.2.1 Plot

5.6.2.2 Summary Table

5.6.3 Behaviour Distribution

5.6.3.1 Plot

5.6.3.2 Summary Table

5.6.4 Staging Distribution

5.6.4.1 Plot

5.6.4.2 Summary Table

5.6.5 Grade Distribution

5.6.5.1 Plot

5.6.5.2 Summary Table

6 Results for 2006 to 2010

7 Results for 2011 to 2015

8 Results for 2016 to 2021

9 Results Overall | 2001 to 2021

10 Appendix

10.1